MNM Bioscience Inc. Company
MNM integrates cutting-edge genomics with the latest breakthroughs in AI to fight cancer. Our goal is to crack the code of tumor biology
Last Funding Type:
Grant
Funding Status:
Seed
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2018-03-01
Investor Type:
contact@mnm.bio
Last Funding Date:
2020-10-20
Total Funding:
4477022
Technology:
['BioTech & HealthTech', 'AI Infrastructure']
Employee Number:
11-50
Investors Number:
2.0
Industry:
Medical BioTech